I-mab logo

I-mab Share Price Today (NASDAQ: IMAB)

I-mab share price is $2.41 & ₹206.62 as on 1 Jul 2025, 01.30 'hrs' IST

$2.41

-0.16

(-6.23%)

Live

View live I-mab share price in Dollar and Rupees. Guide to invest in I-mab stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in I-mab, along with analyst recommendations, forecasts, and comprehensive financials.

I-mab share price movements

  • Today's Low: $2.36
    Today's High: $2.70

    Day's Volatility :12.59%

  • 52 Weeks Low: $0.60
    52 Weeks High: $3.08

    52 Weeks Volatility :80.65%

I-mab (IMAB) Returns

PeriodI-mabSector (Health Care)Index (Russel 2000)
3 Months
211.93%
-7.3%
0.0%
6 Months
192.05%
-2.4%
0.0%
1 Year
58.64%
-8.1%
0.0%
3 Years
-77.63%
4.4%
3.6%

I-mab (IMAB) Key Statistics

in dollars & INR

Previous Close
$2.57
Open
$2.71
Today's High
$2.7
Today's Low
$2.36
Market Capitalization
$165.0M
Today's Volume
$2.6M
52 Week High
$3.075
52 Week Low
$0.595
Revenue TTM
$3.5M
EBITDA
$-48.0M
Earnings Per Share (EPS)
$-0.55
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-19.7%

How to invest in I-mab Stock (IMAB) from India?

It is very easy for Indian residents to invest directly in I-mab from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the I-mab stock in both Indian Rupees (INR) and US Dollars (USD). Search for I-mab or IMAB on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of I-mab or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of I-mab shares which would translate to 0.356 fractional shares of I-mab as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like I-mab, in just a few clicks!

Returns in I-mab (IMAB) for Indian investors in Rupees

The I-mab stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

I-mab investment value today

Current value as on today

₹1,51,611

Returns

₹51,611

(+51.61%)

Returns from I-mab Stock

₹48,765 (+48.77%)

Dollar Returns*

₹2,845 (+2.85%)

Indian investors sentiment towards I-mab (IMAB)

5300.0%

Period: May 30, 2025 to Jun 29, 2025. Change in 30 Days versus previous period

Investment in I-mab Shares from India has grown by 5300.0% over the past 30 days, indicating increased transactional activity.

1033%

Period: May 30, 2025 to Jun 29, 2025. Change in 30 Days versus previous period

Search interest for I-mab Stock from India on INDmoney has increased by 1033% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in I-mab

  • Hillhouse Capital Advisors, Ltd.

    7.32%

  • SG Americas Securities, LLC

    1.01%

  • Stonepine Capital Management Llc

    0.59%

  • Two Sigma Advisers, LLC

    0.44%

  • EDBI Pte Ltd

    0.27%

  • Two Sigma Investments LLC

    0.26%

Analyst Recommendation on I-mab

Rating
Trend

Buy

    90%Buy

    9%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for I-mab(by analysts ranked 0 to 5 stars)

Analyst Forecast on I-mab Stock (IMAB)

What analysts predicted

Upside of 132.37%

Target:

$5.60

Current:

$2.41

Insights on I-mab Stock (Ticker Symbol: IMAB)

  • Price Movement

    In the last 1 month, IMAB stock has moved up by 96.2%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 3.27M → 3.99M (in $), with an average increase of 18.1% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -20.49M → -9.06M (in $), with an average increase of 63.1% per quarter
  • IMAB vs ONC (1 yr)

    In the last 1 year, Beone Medicines Ltd has given 69.1% return, outperforming this stock by 15.2%
  • IMAB vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 49.0% return, outperforming this stock by 126.3%
  • Price to Sales

    ForIMAB every $1 of sales, investors are willing to pay $58.6, whereas for Beone Medicines Ltd, the investors are paying $6.1 for every $1 of sales.

I-mab Technicals Summary

Sell

Neutral

Buy

I-mab is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

I-mab (IMAB) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
I-mab logo
100.78%
192.05%
58.64%
-77.63%
-96.79%
Regeneron Pharmaceuticals, Inc. logo
6.15%
-25.85%
-50.71%
-12.5%
-14.47%
Beone Medicines Ltd logo
-1.92%
31.22%
66.47%
44.47%
27.5%
Vertex Pharmaceuticals Incorporated logo
-0.93%
10.5%
-6.36%
53.59%
54.15%
Alnylam Pharmaceuticals, Inc. logo
5.47%
36.79%
32.68%
117.76%
117.0%

About I-mab

I-Mab, a biotech company, focuses on the development of immuno-oncology agents for the treatment of cancer in the United States. The company is developing givastomig, a bispecific antibody, which is in Phase 1b clinical trial for the treatment of gastric cancer; uliledlimab, a CD73 neutralizing antibody; and ragistomig, a bispecific antibody, which is in phase 1 clinical trial for the treatment of solid tumors. It has a strategic licensing agreement with Ferring International Center SA to research, develop, make, have made, import, use, sell, and offer to sell FE301, an interleukin-6 inhibitor. The company also has collaborations with Bristol Myers Squibb for the development of givastomig; ABL Bio, Inc. for the development of givastomig and ragistomig; and TJ Bio for the development of uliledlimab. I-Mab was founded in 2014 and is headquartered in Rockville, Maryland.
Organization
I-mab
Employees
32
CEO
Dr. Xi-Yong Fu M.B.A., Ph.D.
Industry
Health Technology

Management People of I-mab

NameTitle
Dr. Xi-Yong Fu M.B.A., Ph.D.
CEO & Director
Mr. Skelton Joseph
Chief Financial Officer
Mr. Tyler Ehler
Senior Director of Investor Relations
Dr. Claire Xu M.D., Ph.D.
Senior Vice President of Clinical Development
Dr. Phillip Dennis M.D., Ph.D.
Chief Medical Officer

Important FAQs about investing in IMAB Stock from India :

Can Indians buy I-mab shares?

Yes, Indians can invest in the I-mab (IMAB) from India.

With INDmoney, you can buy I-mab at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy I-mab at zero transaction cost.

How can I buy I-mab shares from India?

It is very easy to buy I-mab from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of I-mab (IMAB) be purchased?

Yes, you can buy fractional shares of I-mab with INDmoney app.

What are the documents required to start investing in I-mab stocks?

To start investing in I-mab, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is I-mab share price today?

I-mab share price today stands at $2.41, Open: $2.16 ; Previous Close: $2.57 ; High: $2.70 ; Low: $2.36 ; 52 Week High: $3.08 ; 52 Week Low: $0.60.

The stock opens at $2.16, after a closing price of $2.57. The stock reached a daily high of $2.70 and a low of $2.36, with a 52-week high of $3.08 and a 52-week low of $0.60.

What are today’s High and Low prices of I-mab Stock (IMAB)?

Today’s highest price of I-mab (IMAB) is $2.70.

Today’s lowest price of I-mab (IMAB) is $2.36.

What is the 52 Week High and Low Range of I-mab Stock (IMAB)?

  • 52 Week High

    $3.08

  • 52 Week Low

    $0.60

What are the historical returns of I-mab (IMAB)?

  • 1 Month Returns

    100.78%

  • 3 Months Returns

    192.05%

  • 1 Year Returns

    58.64%

  • 5 Years Returns

    -96.79%

What is today's market capitalisation of I-mab?

Today's market capitalisation of I-mab IMAB is 165.0M

Who is the Chief Executive Officer (CEO) of I-mab ?

Dr. Xi-Yong Fu M.B.A., Ph.D. is the current Chief Executive Officer (CEO) of I-mab.